Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Acid, Orotic
2. Orotate, Potassium
3. Orotate, Sodium
4. Orotate, Zinc
5. Orotic Acid
6. Potassium Orotate
7. Sodium Orotate
1. 68399-76-8
2. 60388-02-5
3. 4-pyrimidinecarboxylic Acid, 1,2,3,6-tetrahydro-2,6-dioxo-, Zinc Salt (2:1)
4. Zinc;2,4-dioxo-1h-pyrimidine-6-carboxylate
5. Orotic Acid Zinc Salt Dihydrate
6. Zinc 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)
7. Z722242h10
8. Unii-z722242h10
9. Einecs 262-207-4
10. Einecs 269-988-0
11. Zinc Diorotate
12. Orotate Zinc
13. Zinc Orotate 17% 40m
14. Schembl231367
15. Zinc Orotate [who-dd]
16. Dtxsid8071481
17. Bis(1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylato-n3,o4)zinc
18. Mfcd00039121
19. Ft-0641183
20. Q27295098
21. 4-pyrimidinecarboxylic Acid, 1,2,3,6-tetrahydro-2,6-dioxo-, Zinc Complex
22. Zinc, Bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-n3,o4)-, (t-4)-
23. Zinc,bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-kn3,ko4)-,(t-4)-
24. Zinc, Bis(1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylato-.kappa.n3,.kappa.o4)-, (t-4)-
| Molecular Weight | 375.6 g/mol |
|---|---|
| Molecular Formula | C10H6N4O8Zn |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 0 |
| Exact Mass | 373.947705 g/mol |
| Monoisotopic Mass | 373.947705 g/mol |
| Topological Polar Surface Area | 197 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 262 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Zinc Orotate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zinc Orotate, including repackagers and relabelers. The FDA regulates Zinc Orotate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zinc Orotate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zinc Orotate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zinc Orotate supplier is an individual or a company that provides Zinc Orotate active pharmaceutical ingredient (API) or Zinc Orotate finished formulations upon request. The Zinc Orotate suppliers may include Zinc Orotate API manufacturers, exporters, distributors and traders.
click here to find a list of Zinc Orotate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zinc Orotate written confirmation (Zinc Orotate WC) is an official document issued by a regulatory agency to a Zinc Orotate manufacturer, verifying that the manufacturing facility of a Zinc Orotate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zinc Orotate APIs or Zinc Orotate finished pharmaceutical products to another nation, regulatory agencies frequently require a Zinc Orotate WC (written confirmation) as part of the regulatory process.
click here to find a list of Zinc Orotate suppliers with Written Confirmation (WC) on PharmaCompass.
Zinc Orotate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zinc Orotate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zinc Orotate GMP manufacturer or Zinc Orotate GMP API supplier for your needs.
A Zinc Orotate CoA (Certificate of Analysis) is a formal document that attests to Zinc Orotate's compliance with Zinc Orotate specifications and serves as a tool for batch-level quality control.
Zinc Orotate CoA mostly includes findings from lab analyses of a specific batch. For each Zinc Orotate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zinc Orotate may be tested according to a variety of international standards, such as European Pharmacopoeia (Zinc Orotate EP), Zinc Orotate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zinc Orotate USP).
LOOKING FOR A SUPPLIER?
